CVA Family Office’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
9,060
-395
-4% -$57.5K 0.12% 103
2026
Q1
$1.37M Buy
9,455
+21
+0.2% +$3.18K 0.14% 93
2025
Q4
$1.35M Sell
9,434
-659
-7% -$97.2K 0.16% 88
2025
Q3
$1.55M Sell
10,093
-195
-2% -$30.5K 0.2% 79
2025
Q2
$1.64M Sell
10,288
-107
-1% -$17.5K 0.23% 73
2025
Q1
$1.77M Buy
10,395
+191
+2% +$32K 0.27% 63
2024
Q4
$1.71M Buy
10,204
+480
+5% +$81.8K 0.27% 63
2024
Q3
$1.68M Buy
9,724
+151
+2% +$25.6K 0.27% 62
2024
Q2
$1.58M Buy
9,573
+3
+0% +$490 0.28% 63
2024
Q1
$1.55M Buy
9,570
+519
+6% +$81.4K 0.28% 65
2023
Q4
$1.33M Sell
9,051
-724
-7% -$107K 0.26% 64
2023
Q3
$1.43M Buy
9,775
+642
+7% +$98.1K 0.33% 57
2023
Q2
$1.39M Buy
9,133
+342
+4% +$51.5K 0.29% 61
2023
Q1
$1.31M Buy
8,791
+455
+5% +$65K 0.29% 56
2022
Q4
$1.26M Sell
8,336
-336
-4% -$47.1K 0.31% 56
2022
Q3
$1.09M Buy
8,672
+991
+13% +$141K 0.3% 62
2022
Q2
$1.1M Buy
7,681
+526
+7% +$79.1K 0.3% 55
2022
Q1
$1.09M Buy
7,155
+191
+3% +$29.9K 0.26% 63
2021
Q4
$1.14M Buy
6,964
+3,339
+92% +$496K 0.28% 57
2021
Q3
$504K Sell
3,625
-3,426
-49% -$486K 0.36% 49
2021
Q2
$951K Buy
7,051
+1,279
+22% +$173K 0.27% 59
2021
Q1
$782K Buy
5,772
+2,146
+59% +$280K 0.3% 51
2020
Q4
$505K Buy
3,626
+1
+0% +$140 0.31% 52
2020
Q3
$504K Buy
3,625
+436
+14% +$57.9K 0.36% 49
2020
Q2
$381K Buy
3,189
+180
+6% +$21K 0.31% 53
2020
Q1
$331K Buy
3,009
+200
+7% +$24K 0.34% 56
2019
Q4
$351K Buy
+2,809
New +$344K 0.32% 55

Other funds holding PG

CVA Family Office's PG Position: Q2 2026 in Review

CVA Family Office reduced its Procter & Gamble (PG) stake by 4.2% in Q2 2026, selling an estimated $57.5K and leaving 9,060 shares worth $1.33M. The position accounts for 0.12% of the portfolio, ranked #103.

CVA Family Office first reported a position in PG in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.77M in Q1 2025. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • CVA Family Office held 9,060 shares of Procter & Gamble worth $1.33M as of Q2 2026.
  • CVA Family Office sold 395 Procter & Gamble shares in Q2 2026, an estimated $57.5K.
  • Procter & Gamble made up 0.12% of CVA Family Office's portfolio in Q2 2026, its #103 holding.
  • CVA Family Office first reported a position in Procter & Gamble in Q4 2019 and has held it in 27 quarters since.
  • CVA Family Office's Procter & Gamble position peaked at $1.77M in Q1 2025.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.